<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To verify whether <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation is associated with focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, a unilateral middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> was carried out in rats </plain></SENT>
<SENT sid="1" pm="."><plain>The concentrations of various endogenous <z:chebi fb="11" ids="22586">antioxidants</z:chebi> in the ischemic center were measured, including <z:chebi fb="0" ids="22470">alpha-tocopherol</z:chebi> and <z:chebi fb="0" ids="16389">ubiquinones</z:chebi> as <z:chebi fb="23" ids="18059">lipid</z:chebi>-soluble <z:chebi fb="11" ids="22586">antioxidants</z:chebi> and <z:chebi fb="0" ids="22651">ascorbate</z:chebi> as a water-soluble <z:chebi fb="11" ids="22586">antioxidant</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>At 30 minutes after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, <z:chebi fb="0" ids="22470">alpha-tocopherol</z:chebi> decreased to 79% of baseline, reduced <z:chebi fb="0" ids="18160">ubiquinone-9</z:chebi> to 73%, <z:chebi fb="0" ids="46372">ubiquinone-10</z:chebi> to 66%, and reduced <z:chebi fb="0" ids="22651">ascorbate</z:chebi> to 76% </plain></SENT>
<SENT sid="3" pm="."><plain>Six hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, <z:chebi fb="0" ids="22470">alpha-tocopherol</z:chebi> decreased to 63% and reached a plateau, whereas reduced <z:chebi fb="0" ids="16389">ubiquinones</z:chebi> and reduced <z:chebi fb="0" ids="22651">ascorbate</z:chebi> declined further to 16% and 10%, respectively, 12 hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and then reached plateau levels </plain></SENT>
<SENT sid="4" pm="."><plain>These results suggest functional and durational differences between <z:chebi fb="11" ids="22586">antioxidants</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation in this ischemic model </plain></SENT>
<SENT sid="5" pm="."><plain>Although the reciprocal increase in oxidized <z:chebi fb="0" ids="16389">ubiquinones</z:chebi> during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was not observed, that of oxidized <z:chebi fb="0" ids="22651">ascorbate</z:chebi> was noted </plain></SENT>
<SENT sid="6" pm="."><plain>The complementary <z:chebi fb="11" ids="22586">antioxidant</z:chebi> system between cytoplasmic and membranous components, the combination <z:chebi fb="0" ids="22470">alpha-tocopherol</z:chebi>/<z:chebi fb="0" ids="22651">ascorbate</z:chebi>, was estimated from the calculated consumption ratio of these <z:chebi fb="11" ids="22586">antioxidants</z:chebi> on the basis that the loss of these reduced <z:chebi fb="11" ids="22586">antioxidants</z:chebi> is due to neutralization of free radicals </plain></SENT>
<SENT sid="7" pm="."><plain>This system is suggested to play an important role in the early ischemic period </plain></SENT>
<SENT sid="8" pm="."><plain>Urate also increased during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The possible involvement of the <z:chebi fb="1" ids="15318,17712">xanthine</z:chebi>-<z:chebi fb="1" ids="15318,17712">xanthine</z:chebi> oxidase system in initiating free radical reactions in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> is also discussed </plain></SENT>
</text></document>